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PEndothelial Dysfunction
ndothelial Vasomotor Dysfunction
n the Brachial Artery Is Associated
ith Late In-Stent Coronary Restenosis
oshinobu Kitta, MD, Takamitsu Nakamura, MD, Yasushi Kodama, MD, Hajime Takano, MD, PHD,
en Umetani, MD, PHD, Daisuke Fujioka, MD, Yukio Saito, MD, Ken-ichi Kawabata, MD, PHD,
yun-ei Obata, MD, PHD, Yoshihide Ichigi, MD, Akira Mende, MD, Kiyotaka Kugiyama, MD, PHD
amanashi, Japan
OBJECTIVES This study examined whether endothelial dysfunction in the brachial artery might be
associated with late in-stent restenosis (ISR) after percutaneous coronary intervention (PCI).
BACKGROUND Simple and noninvasive identification of late ISR might help to select patients who require
further angiographic evaluation.
METHODS Endothelium-dependent flow-mediated dilation (FMD) of the brachial artery was measured
before (initial FMD) and at six months (follow-up FMD) after PCI in 141 consecutive
patients who had elective and successful PCI with bare metal stents in de novo lesions of
native coronary arteries for symptomatic coronary artery disease. Follow-up angiography was
performed at six months after PCI in all patients.
RESULTS With multivariate logistic regression analysis, the impairment (4.8% dilation from baseline
diameter) of FMD at follow-up showed the strongest association with late ISR (defined as
50% diameter stenosis, n  46) independently of other clinical and angiographic variables
known to be associated with ISR (odds ratio 7.4, 95% confidence interval 2.8 to 19.2, p 
0.001), whereas the initial FMD did not have the association. The sensitivity of impaired
FMD at follow-up (69%) in detecting ISR was higher than chest pain during the follow-up
period (45%), with comparable specificity. The impaired FMD in combination with the chest
pain increased the sensitivity to 90%.
CONCLUSIONS The impairment of FMD in the brachial artery at the time of follow-up was independently
and closely associated with late ISR in native coronary arteries. The noninvasive assessment
of FMD at the time of follow-up might be useful for identification of late ISR. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.04.055Cardiol 2005;46:648–55) © 2005 by the American College of Cardiology Foundation
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tn-stent restenosis (ISR), although less frequent than post-
ngioplasty restenosis, remains a clinical problem, because
here is increasing use of coronary stents for the treatment of
oronary artery disease (CAD). When chest pain develops
uring the follow-up period after stenting, patients might
e recommended for angiographic evaluation to detect ISR
r another coronary stenosis; however, several reports (1–3)
ave shown that approximately 50% of patients remain
symptomatic when restenosis occurs; thus, chest pain after
ercutaneous coronary intervention (PCI) is a poor indica-
or of restenosis. Therefore, a simple and noninvasive
ethod for identifying late restenosis after PCI might help
o select patients who require further angiographic
valuation.
The vascular endothelium suppresses intimal hyperplasia
4,5), an essential pathological feature of ISR (6,7). Fur-
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f Medicine and Engineering, University of Yamanashi, Yamanashi, Japan. This
tudy was supported by grants-in-aid for (B)(2)-15390244, Priority Areas (C)
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ports, Science, and Technology, Health and Labor Sciences Research Grants for
omprehensive Research on Aging and Health (H15-Choju-012), the Smoking
esearch Foundation, Tokyo, Japan.w
Manuscript received January 23, 2005; revised manuscript received April 19, 2005,
ccepted April 25, 2005.hermore, it has been shown that endothelial dysfunction in
ystemic arteries is a strong predictor of future coronary
vents (8,9). Thus, endothelial vasomotor dysfunction in
ystemic arteries in patients with coronary stenting might be
ssociated with the development of ISR. In this study, we
valuated the usefulness of measuring endothelium-
ependent dilation of the brachial artery for the identifica-
ion of ISR.
ETHODS
tudy patients. This study included 141 consecutive pa-
ients who had elective and successful PCI of de novo
esions with bare metal stents in native coronary arteries for
ymptomatic CAD and follow-up coronary angiography at
ix months after the PCI at Yamanashi University Hospital.
atients who had acute coronary syndrome, stroke, or other
erious diseases occurring during the six-month follow-up
eriods were excluded. Patients with congestive heart fail-
re, left main trunk disease, and other serious systemic
iseases were also excluded. This study also included 48
ontrol subjects with angiographically normal coronary ar-
eries and normal ventriculography. These control subjects
ere selected to match the age and gender of the patients
w
v
c
i
a
a
i
s
t
i
S
(
a
w
t
m
g
o
t
z
w
e
t
s
w
t
Y
o
e
q
t
C
i
t
a
w
f
m
w
m
l
B
P
t
a
o
p
(
t
a
s
s
A
n
O
d
s
a
e
a
d
Q
o
t
a
Q
p
M
t
(
d
l
a
d
d
s
t
I
a
r
I
g
l
M
t
B
t
v
w
K
T
a
o
T
o
m
c
649JACC Vol. 46, No. 4, 2005 Kitta et al.
August 16, 2005:648–55 Endothelial Dysfunction and ISRith PCI, and they were studied to compare endothelial
asomotor function with that of the PCI patients. The
haracteristics of the patients and control subjects are shown
n Table 1. All patients were informed that the follow-up
ngiography would be required, regardless of ischemia/
nginal symptoms, according to the study protocol. Written
nformed consent was obtained from all patients and control
ubjects before the study. This study was in agreement with
he guidelines approved by the ethics committee at our
nstitution.
tudy protocol. Measurement of flow-mediated dilation
FMD) in the brachial artery was performed in the morning
fter an overnight fast in the same manner in all study patients,
ithin three days before the PCI and within three days before
he follow-up coronary angiography, at the end of the six-
onth follow-up period. An exercise treadmill electrocardio-
raphic (ECG) test was performed in the morning after
vernight fasting a day before the follow-up FMD. Vasodila-
ors, including calcium blockers, angiotensin-converting en-
yme inhibitors, and angiotensin receptor blockers were
ithdrawn 48 h before the FMD measurement and the
xercise stress test. Beta-blockers were discontinued more
han 12 h before the FMD measurement and the exercise
tress test. Sublingual nitroglycerin was allowed to be used
hen ischemia/anginal symptoms were developed. All of
he examinations were performed during hospital stay at
amanashi University Hospital. The ECG was continu-
usly and carefully monitored during the hospital stay to
nsure the safety of the patients. All patients were routinely
uestioned for the presence or absence of chest pain during
he six-month follow-up period according to Canadian
ardiovascular Society angina classification class (10) by
nvestigators (Drs. Saito and Fujioka) without knowledge of
he follow-up angiographic results. In addition, physical
ctivity (average min/day), especially leisure-time activity,
as assessed with a questionnaire at the end of the
ollow-up period. All of the patients received standard
edical therapy during the follow-up period. Venous blood
as obtained from all patients immediately before FMD
easurement. High-sensitivity C-reactive protein (hsCRP)
evels in the serum were assayed by rate nephelometry (Dade
Abbreviations and Acronyms
CAD  coronary artery disease
ECG  electrocardiography
FMD  flow-mediated dilation
HDL-C  high-density lipoprotein cholesterol
hsCRP  high-sensitivity C-reactive protein
ISR  in-stent restenosis
MLD  minimal lumen diameter
PCI  percutaneous coronary intervention
TLR  target lesions revascularization (defined as
repeat percutaneous coronary intervention of
the original stented target lesions)ehring, Marburg, Germany). sCI. Coronary angioplasty was performed with the Judkins
echnique without intracoronary ultrasound scanning guid-
nce under systemic heparinization and oral administration
f aspirin and ticlopidine. The stent type and inflation
ressure were chosen at the discretion of the physicians
Drs. Takano, Umetani, and Obata), who were blinded to
he study protocol and the data regarding FMD. Rotablator
nd directional atherectomy were not performed in the
tented coronary lesions in any study patients. Procedural
uccess was defined as a residual lumen narrowing 20%.
fter PCI, patients received aspirin (100 mg/day) indefi-
itely and ticlopidine (200 mg/day) at least for four weeks.
riginal stented target lesions revascularization (TLR) was
efined as repeated PCI or surgical bypass of the original
tented lesions and was performed in the presence of ISR
nd any symptoms or objective signs of myocardial isch-
mia. Even if the symptoms or the objective signs were
bsent, TLR was performed in the presence of 75%
iameter stenosis in the stented lesions.
uantitative coronary angiography. All patients had cor-
nary angiography before and immediately after PCI and at
he planned six-month follow-up in multiple projections
fter intracoronary injection of 1 mg of isosobide dinitrate.
uantitative coronary angiography was conducted with the
rojection that revealed the highest degree of stenosis.
easurements were performed with CARDIO500 (Kon-
ron Instruments Inc., Everett, Massachusetts) by operators
Drs. Ichigi and Mende) who were blinded to the FMD
ata. Lesion length, reference lumen diameter, minimal
umen diameter (MLD), stented segment length, and di-
meter stenosis were measured with an automated edge-
etection system. Late lumen loss was defined as the
ifference between the post-PCI MLD and the MLD at the
ix-month follow-up. When a lesion was totally occluded,
he lesion length was measured after opening the occlusion.
n-stent restenosis was defined as 50% diameter stenosis
t the stented site on the follow-up angiogram. Patients that
equired stents in multilesions were classified as positive for
SR, if it occurred in at least one lesion. The lesion with the
reatest lumen loss was analyzed in patients with multi-
esions intervention.
easurements of FMD in the brachial artery. Vasodila-
or responses in the brachial arteries were measured with
-mode ultrasound images with a 7.5-MHz linear array
ransducer (HP-5500, Phillips Corp., Tokyo, Japan), as
alidated in our previous studies (11,12). Measurements
ere performed by two observers (Drs. Nakamura and
itta) who were blinded to the coronary angiography data.
he brachial artery was scanned in the antecubital fossa in
longitudinal fashion. Optimal brachial artery images were
btained between 1 and 5 cm above the antecubital crease.
his location was marked, and all subsequent images were
btained at the same location. The exact distance of the
easured point of the skin surface from the antecubital
rease was recorded in each subject to ensure that the same
egment of the brachial artery was measured at each time
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Endothelial Dysfunction and ISR August 16, 2005:648–55oint during follow-up. The gain setting was optimized at
he beginning of the study and was kept constant through-
ut the recording period. After baseline measurements of
he diameter and flow velocity in the brachial artery, a blood
ressure cuff was placed around the forearm and inflated to
pressure of 250 to 300 mm Hg for 5 min and then
eleased. Diameter measurements during reactive hyperemia
ere taken 45 to 90 s after cuff deflation. Then, sublingual
itroglycerin (0.3 mg) was administered, and three min
ater, the measurements were repeated. Images were re-
orded on a super-VHS videocassette recorder (model
R-S601M, Victor Corp., Tokyo, Japan), and brachial
rterial diameters were measured from the tape with ultra-
onic calipers as described previously (11,12). The response
f the vessel diameter to reactive hyperemia and nitroglyc-
rin were expressed as a percentage increase in diameter
rom the baseline value. The diameter responses were
ssessed at three points along a 10-mm length of the artery,
nd the diameter responses were averaged. Blood flow was
alculated by multiplying the velocity-time integral of the
oppler flow signal by heart rate and the vessel cross-
ectional area. The increase in brachial blood flow was
Table 1. Comparisons of Clinical, Lesion, and
Patients With and Without ISR
Clinical variables
Age (yrs)
Male (%)
Hypertension (%)
Diabetes mellitus (%)
Smoker (%)
Family history (%)
Total cholesterol (mg/dl)
LDL cholesterol (mg/dl)
HDL cholesterol (mg/dl)
HbA1c (mg/dl)
hsCRP (mg/dl)
Prior myocardial infarction (%)
Lesion variables
LAD intervention (%)
ACC/AHA lesion type B2/C (%)
Infarct-related artery (%)
Multivessel disease (%)
Multivessel intervention (%)
Multilesion intervention (%)
Chronic total occlusion (%)
Number of stents
Coil stent (%)
Measurement with quantitative coronary angiograph
Stented segment length (mm)
Reference diameter (mm)
MLD before PCI (mm)
MLD after PCI (mm)
Lesion length (mm)
*p  0.05 versus control subjects, †p  0.05, ‡p  0.01
antihypertensive medication; smoking, 10 cigarettes/day for
Diabetes Association report or as taking an antidiabetic medica
ACC/AHA  American College of Cardiology/America
glycosylated hemoglobin; hsCRP  high-sensitivity C-reactive
descending; LDL  low-density lipoprotein; MLD  minimal lualculated as the maximum flow recorded in the first 15 s
fter cuff deflation and was expressed as a percentage
ncrease in flow from the baseline value.
xercise stress test. Symptom-limited treadmill exercise
esting was performed with the Bruce protocol while re-
ording a 12-lead ECG in 116 (82%) patients in the
orning after overnight fasting at the end of the six-month
ollow-up period. The remaining 25 (18%) patients could
ot have the exercise stress test because of disability. A cuff
lood pressure was recorded every min before and during
xercise. Vasodilators and beta-blockers were discontinued
ore than 12 h before the exercise test. The exercise stress
est was considered positive if 0.1 mV ST-segment
epression occurred with or without chest pain.
tatistical analysis. Data are expressed as mean  SD
nless otherwise indicated. The mean value and frequency
etween two groups were compared with the Student
npaired t test and chi-square analysis, respectively. The
ean values among three groups were compared with
ne-way analysis of variance, followed by a Scheffe test for
ost-hoc comparisons between groups. Chi-square test
ollowed by Tukey test was used for comparing frequencies
edural Variables at Baseline Between
Controls
(n  48)
With ISR
(n  46)
Without ISR
(n  95)
65  12 66  13 65  12
69 66 69
40 69* 73*
17 32 29
23 41 34
18 20 20
200  38 198  29 200  40
118  32 119  29 122  33
58  13 51  14 50  12*
5.4  0.8 6.2  1.7* 5.8  1.3
0.12  0.09 0.23  0.15* 0.22  0.13*
15 13
67 51
66 42
50 31†
36 37
10 10
31 11‡
5 5
1.3  0.4 1.1  0.3
9 7
19  4.5 17  4.7†
2.97  0.48 3.05  0.73
0.59  0.05 0.64  0.59
2.35  0.48 2.52  0.67
12.7  4.37 10.9  4.03†
s with ISR; hypertension, 140/90 mm Hg or taking an
years; diabetes mellitus, defined according to the American
ata are expressed as mean  SD or percentage of the patients.
rt Association; HDL  high-density lipoprotein; HbA1c Proc
y
versu
10
tion. D
n Heaprotein; ISR  in-stent restenosis; LAD  left anterior
men diameter; PCI  percutaneous coronary intervention.
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August 16, 2005:648–55 Endothelial Dysfunction and ISRmong three groups. Comparisons of FMD in patients with
oronary stenting were performed with two-way analysis of
ariance for repeated measures, followed by post-hoc testing
ith a Scheffe test. The correlation of FMD with risk factor
rofiles was examined by linear regression analysis. The
ssessment of independent association of late ISR and TLR
ith the impairment of the follow-up FMD was performed
ith multivariate logistic regression analysis that included
he following factors as categorical variables: impairment of
he follow-up FMD (4.8%, obtained from receiver-
perator characteristic analysis of FMD in the study pa-
ients), chest pain, positive exercise ECG test, infarct-
elated artery, lesion length (10 mm, arbitrarily defined as
he 50th percentile of the distribution of the length in the
tudy patients), multiple lesions with stenting, stented
egment length (18 mm, arbitrarily defined as the 50th
ercentile of the distribution of the length in the study
atients). All these variables had a significant relationship
ith late ISR in the Student unpaired t test or chi-square
nalysis. Statistical significance was defined as p  0.05.
nalyses were assessed, in part, with StatView 5.0 for
indows (Tokyo, Japan).
ESULTS
omparisons of clinical characteristics between patients
ith and without ISR. In-stent restenosis was found in 46
33%) patients at the follow-up coronary angiography.
atients with and without ISR had comparable clinical
haracteristics, including coronary risk factors and frequen-
ies of each of the cardiac medications before PCI and
uring the six-month follow-up (Tables 1, 2, and 3). Also,
requencies of newly started or increased cardiac medica-
ions immediately after PCI were not significantly different
etween patients with and without ISR (Table 2). Levels of
otal cholesterol, high-density lipoprotein cholesterol
HDL-C), glycosylated hemoglobin (HbA1c), high-
ensitivity C-reactive protein (hsCRP), systolic blood pres-
ure, and body mass index at follow-up were improved
ompared with baseline in both groups of patients, and
here was a reduction in the number of smokers and an
ncrease in leisure-time physical activity, mainly by walking
30 min/day increase from baseline activity for1 month)
uring the treatment periods in both groups (Table 3).
hese favorable changes, however, were not significantly
ifferent between patients with and without ISR (Table 3).
uring the six-month follow-up period, chest pain occurred
n 21 (46%) of 46 patients with ISR and in 12 (13%) of the
5 patients without ISR (p  0.01), as shown in Table 3.
lthough all of the study patients had the follow-up
ngiography and the discontinuation of the vasodilators
efore the measurements, according to the study protocol,
here was neither an adverse complication nor refractory
yocardial ischemia associated with the examinations in
ny patients. cuantitative coronary angiography. Patients with ISR
ad a higher prevalence of infarct-related artery and multi-
le lesions with stenting, longer stented segment length,
nd longer lesion length at the time of the stenting than
hose without ISR (Table 1). Target lesions revasculariza-
ion at the six-month follow-up angiography was performed
ith PCI in 36 (78%) patients with ISR. Percutaneous
oronary intervention for coronary segments other than the
tented segments was performed at the six-month follow-up
ngiography in 5 (11%) patients with ISR and 8 (8%)
atients without ISR (p  NS).
xercise treadmill ECG test. The exercise ECG test was
erformed in 41 (89%) patients with ISR and 75 (79%)
atients without ISR (p  NS). Among patients who had
he exercise stress test, the test was positive in 22 (54%)
atients with ISR and 17 (23%) patients without ISR (p 
.01). Chest pain during the exercise test occurred in 15
37%) patients with ISR and 5 (7%) patients without ISR (p
0.01).
MD. The initial FMD within three days before the
able 2. Comparisons of Frequency in Use of Medications
efore PCI, Newly Added or Increased Immediately After PCI,
nd Medications During the Follow-Up Period
With ISR
(n  46)
Without ISR
(n  95)
edications before PCI
Statin (%) 14 10
ACE-I (%) 6 10
ARB (%) 11 9
Calcium channel blocker (%) 20 22
Beta-blocker (%) 4 5
Aspirin (%) 50 42
Ticlopidine (%) 39 34
Sulfonylurea (%) 11 7
Insulin (%) 4 2
edications added or increased after
PCI
Statin (%) 26 23
ACE-I (%) 26 33
ARB (%) 17 14
Calcium channel blocker (%) 43 45
Beta-blocker (%) 22 23
Aspirin (%) 50 58
Ticlopidine (%) 51 58
Sulfonylurea (%) 2 3
Insulin (%) 4 2
edications during the follow-up period
Statin (%) 38 32
ACE-I (%) 31 42
ARB (%) 28 19
Calcium channel blocker (%) 62 65
Beta-blocker (%) 26 27
Aspirin (%) 100 100
Ticlopidine (%) 90 92
Sulfonylurea (%) 13 10
Insulin (%) 9 4
here was no statistical difference in frequencies of medications between the two
roups.
ACE-I angiotensin-converting enzyme inhibitors; ARB angiotensin receptor
lockers; ISR  in-stent restenosis; PCI  percutaneous coronary intervention.oronary stenting was comparable between patients with
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Endothelial Dysfunction and ISR August 16, 2005:648–55nd without ISR, and the initial FMD was lower in patients
ith or without ISR than in the age- and gender-matched
ontrol subjects (Fig. 1). In patients without ISR, the FMD
t the end of the six-month follow-up period improved to
evels comparable to the control subjects, whereas the
ollow-up FMD in patients with ISR did not significantly
hange compared with the initial FMD (Fig. 1). As a result,
he follow-up FMD was lower in patients with ISR than
ithout ISR. Dilator responses to nitroglycerin, brachial
Table 3. Comparisons of Clinical Data During
and Without ISR
Wi
(n
Risk status at the follow-up
Total cholesterol (mg/dl) 186
LDL cholesterol (mg/dl) 109
HDL cholesterol (mg/dl) 54
HbA1c (mg/dl) 5.9
hsCRP (mg/dl) 0.17
Systolic blood pressure (mm Hg) 121
BMI (kg/m2) 24
Change of risk status from baseline
Change of total cholesterol (%) 4.7
Change of LDL-C (%) 5.9
Change of HDL-C (%) 8.7
Change of HbA1c (%) 3.2
Change of hsCRP (%) 26
Change of SBP (%) 5.1
Change of BMI (%) 6.1
Cessation of smoking (%) 61
Increase in physical activity (%)
Chest pain
Asymptomatic (%)
CCS class
I (%)
II (%)
III (%)
IV (%)
Data are expressed as mean  SD or percentage of the pati
BMI  body mass index; CCS  Canadian Cardiovascu
hemoglobin; SBP  systolic blood pressure. Other abbrevia
igure 1. Comparison of flow-mediated dilation (FMD) of the brachial
rtery at coronary stenting (Initial) and at the six-month follow-up
Follow-up) between patients with (n  46) and without (n  95) in-stent
estenosis (ISR). The control subjects (n  48) with normal coronary
ngiograms were selected to match age and gender of the patients with
tenting and served as comparison of FMD with the patients. Data area
xpressed as mean SE. *p 0.01 versus initial FMD in patients without
SR; †p  0.01 versus control subjects.rterial diameter at baseline, and brachial blood flow at
aseline, and increase in the blood flow at reactive hyper-
mia were not significantly different among control subjects
nd patients with or without ISR at either the initial time or
he end of the follow-up period (Table 4). The extent of the
mprovement of the follow-up FMD from the initial FMD
n patients without ISR significantly correlated with the
ercentage changes in levels of total cholesterol (r  0.36,
 0.01), HDL-C (r  0.34, p  0.05), HbA1c (r 
0.37, p  0.05), and hsCRP (r  0.32, p  0.05) from
aseline to follow-up, whereas there was no significant
orrelation in patients with ISR (data not shown).
ssociation of the angiographic findings and FMD. The
ate luminal loss significantly and inversely correlated with
he follow-up FMD, whereas it did not correlate with the
nitial FMD (Fig. 2). Furthermore, the late luminal loss
nversely correlated with changes in the follow-up FMD
rom the initial FMD (Fig. 2). In multivariate logistic
tatistical analysis, ISR at the six-month follow-up period
as most strongly associated with the impairment of the
ollow-up FMD (Table 5). This association was indepen-
ent of the infarct-related artery, longer lesion length,
ultiple lesions with stenting, longer stented segment
ength, chest pain during the follow-up period, and a
ositive exercise stress test at the end of the six-month
ollow-up period (Table 5). Also, TLR was significantly
Follow-Up Period Between Patients With
R
)
Without ISR
(n  95) p Value
3 183  32 NS
8 104  28 NS
3 53  12 NS
.1 5.8  1.1 NS
.16 0.15  0.17 NS
5 126  20 NS
.6 24  2.9 NS
9 6.2  17 NS
9 9.7  26 NS
.2 7.3  1.8 NS
.1 2.3  1.2 NS
2 32  60 NS
.8 5.1  1.7 NS
.9 5.3  2.5 NS
8) 66 (21/32) NS
20 NS
87 0.01
11 0.01
2 0.05
0
0
ciety angina classification class (10); HbA1c  glycosylated
s in Tables 1 and 2.the
th IS
 46
 3
 2
 1
 1
 0
 1
 2
 1
 2
 2
 1
 3
 1
 1
(11/1
18
54
22
7
4
3
ents.ssociated with the impairment of the follow-up FMD
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August 16, 2005:648–55 Endothelial Dysfunction and ISRndependently of the same co-variables (odds ratio 4.95;
5% confidence interval 1.95 to 12.5, p  0.005).
ensitivity and specificity for identification of late ISR
nd TLR. The sensitivity of the impairment of the
ollow-up FMD (69%) for the identification of late ISR was
ignificantly higher than chest pain during the follow-up
eriod (46%), and it was also nearly higher than a positive
xercise stress test at the end of the six-month follow-up
eriod (54%) (Table 6). The specificity among these three
ssessments was not statistically different. The assessment of
he follow-up FMD in combination with chest pain during
he follow-up period had an incremental effect on the
ensitivity for the identification of late ISR, and the im-
aired FMD at follow-up in combination with chest pain
uring the follow-up increased the sensitivity to 90% (Table
, Fig. 3). In addition, the impaired FMD in combination
igure 2. Correlations of late luminal loss with flow-mediated dilation
FMD) at coronary stenting (Initial FMD, upper panel), at the six-month
able 4. Brachial Artery Diameter and Blood Flow
Controls
rterial diameter at rest (mm) 3.9  0.6 3
esting arterial blood flow (ml/min) 195  14 1
ncrease in arterial blood flow (%) 221  18 2
ncrease in diameter after NTG (%) 18.1  5.8 17
SR  in-stent restenosis; NTG  nitroglycerin.ollow-up (Follow-up FMD, middle panel), and with changes in FMD
rom the initial FMD to the follow-up FMD (lower panel).
C
iith the positive exercise ECG test had an incremental
ffect on the sensitivity in detecting ISR (Fig. 3). The
ensitivity and specificity of the follow-up FMD for TLR
ere 69% and 70%, respectively. The sensitivity for TLR of
he combined assessment of the follow-up FMD and chest
ain was 94%.
ISCUSSION
he present study showed that impairment of FMD during
he follow-up period was associated with the late diameter
oss and ISR after stenting in native coronary arteries. The
ssociation was independent of clinical and angiographic
ariables known to be related to ISR. Thus, endothelial
asomotor function in a systemic artery might be impor-
antly linked with the pathobiological process of ISR. It was
reviously shown that endothelial-derived nitric oxide sup-
resses smooth muscle proliferation, leading to inhibition of
ntimal hyperplasia after vascular injury in animal models
4,5). Endothelial vasomotor function of the brachial artery
as been shown to reflect nitric oxide-mediated dilation of
he coronary arteries (13). These previous findings might
xplain the relationship between ISR and endothelial vaso-
otor dysfunction of the brachial artery in the present
tudy, although the initial FMD did not predict ISR.
ndothelial vasomotor function, a sensitive indicator of
arly development of atherosclerosis, is reversible and can be
odified in parallel with changes in coronary risk status
14–16). All the study patients had well-established pro-
hylactic treatments such as lipid-lowering medication and
ife style changes for cardiovascular disease after the first-
ime PCI. In fact, both patients with and without ISR had
avorable changes with similar degrees in levels of lipids,
bA1c, and hsCRP, body mass index, smoking status, and
hysical activity during the six-month follow-up period.
With ISR Without ISR
l Follow-Up Initial Follow-Up
0.6 3.9  0.4 3.9  0.5 3.9  0.6
20 190  25 190  23 192  18
14 216  12 217  18 219  16
5.4 18.1  5.3 17.5  5.6 17.4  7.1
able 5. Multivariate Logistic Regression Analysis; Association
f ISR With FMD, Clinical, Lesion, and Procedural Variables
OR 95% CI p Value
ollow-up FMD (4.8%) 7.39 2.83–19.2 0.0001
ositive exercise test 4.68 1.61–13.6 0.01
nfarct-related artery 2.91 1.13–7.51 0.02
esion length (10 mm) 2.51 0.99–6.41 0.05
ultiple lesions with stenting 2.46 0.88–8.64 0.08
hest pain 2.43 0.81–7.27 0.11
tented segment length (18 mm) 2.08 0.77–5.59 0.14Initia
.9 
87 
18 
.7 I  confidence interval; FMD  flow-mediated dilation of brachial artery; ISR 
n-stent restenosis; OR  odds ratio.
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Endothelial Dysfunction and ISR August 16, 2005:648–55he favorable changes in some of these risk factors, such as
otal cholesterol levels, HDL-C levels, HbA1c, and hsCRP,
ere significantly related to the improvement of FMD at
ollow-up in patients without ISR. These treatment-related
eductions in the atherogenic burden improved endothelial
asomotor dysfunction, leading to attenuation of the intimal
hickening of coronary arteries after stenting in patients
ithout ISR; the reduction in these risk factors, however,
ailed to improve FMD in patients with ISR in spite of the
imilar treatments and reductions in risk factors. The
eversibility of endothelial dysfunction in response to reduc-
ion in atherogenic burden might vary among individuals
17). The mechanisms that might explain the different
esponses of the follow-up FMD to the similar anti-
therosclerotic treatments and atherosclerotic burden be-
ween patients with and without ISR remain unknown.
nknown or other risk factors, not examined in the present
tudy, might importantly affect reversibility of endothelial
ysfunction in response to reduction in atherosclerotic
urden. The normalization of endothelial dysfunction could
e related to suppression of the intimal growth within stent
fter PCI, leading to attenuation of ISR; however, persistent
mpairment of endothelial dysfunction might fail to sup-
ress it.
Although risk factor status at the end of the six-month
ollow-up period in patients without ISR was similar or still
omewhat high compared with control subjects, the
ollow-up FMD in patients without ISR was improved to
evels comparable to the control subjects. This might be
xplained by the higher frequencies in use of statins,
ngiotensin-converting enzyme inhibitors, and angiotensin
eceptor blockers, which have pleiotropic endothelial pro-
ective actions, in these patients than in control subjects
data not shown).
The present study also showed that the sensitivity of
MD impairment at follow-up in detecting late ISR was
ignificantly higher or nearly higher than chest pain during
he follow-up period and the positive exercise ECG test at
he end of the follow-up period. The specificity among
hese three assessments was comparable. Furthermore,
MD impairment at follow-up in combination with chest
ain during follow-up resulted in an incremental improve-
able 6. Sensitivity and Specificity for Identification of ISR
Chest Pain
(n  141)
Positive Exerc
(n  116
ensitivity (%) 46 (21/46) 54 (22/41
pecificity (%) 87 (83/95) 77 (58/75
ositive predictive value (%) 63 (21/33) 56 (22/39
egative predictive value (%) 77 (83/108) 75 (58/77
ccuracy (%) 74 (104/141) 69 (80/11
p  0.05 versus chest pain; †p  0.05 versus positive exercise test; ‡p  0.05 versu
ISR  in-stent restenosis; FMD  flow-mediated dilation.ent in sensitivity (90% in patients with impaired FMD
(
end chest-pain). Although the combined assessment did not
ignificantly improve the specificity (83%) compared with
ach individual assessment, the sensitivity and specificity of
he presence of impaired FMD at follow-up in combination
ith chest pain during follow-up appeared similar to the
0% to 95% sensitivity and 70% to 95% specificity that has
een reported for detection of late ISR with stress myocar-
ial perfusion scintigraphy (1,18). Also, results that are
imilar to ISR were obtained with TLR. The assessment of
MD is easily applied in clinical practice and requires only
onventional equipment for vascular ultrasonography. Thus,
he assessment of endothelial vasomotor dysfunction of the
rachial artery during the follow-up period was useful for
he identification of late ISR and TLR after stenting,
specially when combined with the assessment of chest pain
r the stress tests.
A previous report (19) showed an association between
SR and vasodilator dysfunction of forearm resistance ves-
els in a smaller number of patients. Unfortunately, this
eport failed to evaluate the influence of clinical, angio-
igure 3. Incremental effects on the relative risk for late in-stent restenosis
f the combination of impairment of follow-up flow-mediated dilation
st
Impairment of Follow-Up FMD
All Patients
(n  141)
Patients With
Chest Pain
(n  33)
Patients Without
Chest Pain
(n  108)
69* (32/46) 90*† (19/21) 52 (13/25)
75 (71/95) 83 (10/12) 73 (61/83)
57 (32/56) 90*†‡ (19/21) 37 (13/35)
84 (71/85) 83 (10/12) 84 (61/73)
73 (103/141) 87 (29/33) 67 (74/108)
airment of follow-up FMD in all patients.ise Te
)
)
)
)
)
6)FMD) with chest-pain positive (upper panel) and positive exercise
lectrocardiographic test (lower panel).
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August 16, 2005:648–55 Endothelial Dysfunction and ISRraphic, and procedural factors on the association between
SR and vasodilator function with multivariate statistical
nalysis. In addition, there was no information reported
ith regard to the clinical usefulness of the association
etween ISR and vasodilator function. In another recent
eport (20) published during preparation of our present
aper, an impairment of FMD at 30 days after PCI
redicted ISR in patients with recurrent anginal symptoms
r inducible myocardial ischemia at the six-month follow-up,
lthough our study showed that an impairment of FMDbefore
CI did not predict ISR. It is possible that local coronary
njury with PCI might affect their positive association of
mpaired FMD at 30 days after the procedure with ISR
21). Furthermore, this report (20) repeated the follow-up
ngiography only in patients with inducible ischemia (17%
f the total patients), thereby the association between an
mpaired FMD and the angiographic ISR was not precisely
etermined in the study (20).
Although drug-eluting stents limit ISR, it remains to be
etermined whether endothelial dysfunction in systemic
rteries might be also associated with ISR with drug-eluting
tents, especially in high-risk patients with complex lesions.
In conclusion, the impairment of FMD at the follow-up
ime was independently and closely associated with late ISR
fter stenting in the native coronary arteries. The assessment
f FMD at the time of follow-up might be useful for
dentification of late ISR after stenting.
eprint requests and correspondence: Dr. Kiyotaka Kugiyama,
epartment of Internal Medicine II, Interdisciplinary Graduate
chool of Medicine and Engineering, University of Yamanashi,
110 Shimokato, Nakakoma-gun, Yamanashi, 409-3898 Japan.
-mail: kugiyama@yamanashi.ac.jp.
EFERENCES
1. Giedd KN, Bergmann SR. Myocardial perfusion imaging following
percutaneous coronary intervention: the importance of restenosis,
disease progression, and directed reintervention. J Am Coll Cardiol
2004;43:328–36.
2. Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful
percutaneous transluminal coronary angioplasty: serial angiographic
follow-up of 229 patients. J Am Coll Cardiol 1988;12:616–23.
3. Ruygrok PN, Webster MW, de Valk V, et al. Clinical and angio-
graphic factors associated with asymptomatic restenosis after percuta-
neous coronary intervention. Circulation 2001;104:2289–94.4. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC.
Direct evidence for the importance of endothelium-derived nitric
oxide in vascular remodeling. J Clin Invest 1998;101:731–6.
5. Cayatte AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of
nitric oxide production accelerates neointima formation and impairs
endothelial function in hypercholesterolemic rabbits. Arterioscler
Thromb 1994;14:753–9.
6. Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic
coronary stenting in humans. Circulation 1999;99:44–52.
7. Schwartz RS, Henry TD. Pathophysiology of coronary artery reste-
nosis. Rev Cardiovasc Med 2002;3 Suppl 5:S4–9.
8. Fichtlscherer S, Breuer S, Zeiher AM. Prognostic value of systemic
endothelial dysfunction in patients with acute coronary syndromes:
further evidence for the existence of the “vulnerable” patient. Circu-
lation 2004;110:1926–32.
9. Gokce N, Keaney JF Jr., Hunter LM, Watkins MT, Menzoian JO,
Vita JA. Risk stratification for postoperative cardiovascular events via
noninvasive assessment of endothelial function: a prospective study.
Circulation 2002;105:1567–72.
0. Hemingway H, Fitzpatrick NK, Gnani S, et al. Prospective validity of
measuring angina severity with Canadian Cardiovascular Society class:
the ACRE study. Can J Cardiol 2004;20:305–9.
1. Kugiyama K, Motoyama T, Doi H, et al. Improvement of endothelial
vasomotor dysfunction by treatment with alpha-tocopherol in patients
with high remnant lipoproteins levels. J Am Coll Cardiol 1999;33:
1512–8.
2. Motoyama T, Kawano H, Kugiyama K, et al. Vitamin E administra-
tion improves impairment of endothelium-dependent vasodilation in
patients with coronary spastic angina. J Am Coll Cardiol 1998;32:
1672–9.
3. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of
endothelial function in the human coronary and peripheral circula-
tions. J Am Coll Cardiol 1995;26:1235–41.
4. Tamai O, Matsuoka H, Itabe H, et al. Single LDL apheresis improves
endothelium-dependent vasodilatation in hypercholesterolemic hu-
mans. Circulation 1997;95:76–82.
5. Cannon RO III. Cardiovascular benefit of cholesterol-lowering ther-
apy: does improved endothelial vasodilator function matter? Circula-
tion 2000;102:820–2.
6. Kawano H, Motoyama T, Ohgushi M, Kugiyama K, Ogawa H, Yasue
H. Menstrual cyclic variation of myocardial ischemia in premenopausal
women with variant angina. Ann Intern Med 2001;135:977–81.
7. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role
of reversible endothelial dysfunction in hypertensive postmenopausal
women. J Am Coll Cardiol 2002;40:505–10.
8. Beygui F, Le Feuvre C, Maunoury C, et al. Detection of coronary
restenosis by exercise electrocardiography thallium-201 perfusion im-
aging and coronary angiography in asymptomatic patients after per-
cutaneous transluminal coronary angioplasty. Am J Cardiol 2000;86:
35–40.
9. Wu TC, Chen YH, Chen JW, et al. Impaired forearm reactive
hyperemia is related to late restenosis after coronary stenting. Am J
Cardiol 2000;85:1071–6.
0. Patti G, Pasceri V, Melfi R, et al. Impaired flow-mediated dilation and
risk of restenosis in patients undergoing coronary stent implantation.
Circulation 2005;111:70–75.
1. Lerman A. Restenosis, another “dysfunction” of the endothelium.
Circulation 2005;111:8–10.
